Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA   US9216591084

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/13/2013 05/14/2013 05/15/2013 05/16/2013 05/17/2013 Date
5.39(c) 5.52(c) 5.51(c) 5.5(c) 6.58(c) Last
552 568 300 628 419 732 281 509 3 377 899 Volume
+2.28% +2.41% -0.18% -0.18% +19.64% Change
More quotes
Company
Surperformance© rating of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More about the company
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 33,4 M
EBIT 2013 -24,0 M
Net income 2013 -26,9 M
Debt 2013 -
Yield 2013 -
Sales 2014 48,6 M
EBIT 2014 -23,4 M
Net income 2014 -23,3 M
Debt 2014 -
Yield 2014 -
PER 2013 -
PER 2014
Capi. / Sales 2013 5,58x
Capi. / Sales 2014 3,84x
Capitalization 187 M
More Financials
Latest news on VANDA PHARMACEUTICALS INC.
05/09 VANDA PHARMACEUTICALS INC.: Vanda Pharmaceuticals Reports First Quarter 2013 Re..
04/18 VANDA PHARMACEUTICALS INC.: Vanda Pharmaceuticals to Announce First Quarter 201..
04/17 VANDA PHARMACEUTICALS INC.: Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As..
04/04 VANDA PHARMACEUTICALS INC.: Vanda Pharmaceuticals to Present at the BioCentury ..
03/25 VANDA PHARMACEUTICALS INC.: Vanda Reports Successful Completion Of Pre-NDA Meet..
03/14 VANDA PHARMACEUTICALS INC.: Vanda Withdraws Its Marketing Authorization Applica..
02/27 VANDA PHARMACEUTICALS INC.: Vanda Pharmaceuticals to Present at the Cowen and C..
02/12 VANDA PHARMACEUTICALS INC.: Vanda Pharmaceuticals Reports Fourth Quarter 2012 a..
02/07VANDA PHARMACEUTICALS INC.: quaterly earnings release
01/31 VANDA PHARMACEUTICALS INC.: Vanda Announces Phase IIb/III Clinical Study In Maj..
01/23 VANDA PHARMACEUTICALS INC.: Vanda Announces Positive Results in the Second Phas..
01/22 VANDA PHARMACEUTICALS INC.: Vanda Pharmaceuticals to Announce Fourth Quarter 20..
More news
Forum VANDA PHARMACEUTICALS INC.
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Vanda Pharmaceuticals Inc. : Income Statement Evolution
More Financials
EPS Revisions
Vanda Pharmaceuticals Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.